| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.13B | -2.3% |
| Cost of Revenue | $465.1M | -9.9% |
| Gross Profit | $663.3M | +3.8% |
| R&D Expense | $138.1M | -14.0% |
| SG&A Expense | $154.6M | +8.3% |
| Operating Income | $190.8M | +170.5% |
| Interest Expense | $68.0M | +22.2% |
| Pre-tax Income | $131.8M | +142.3% |
| Income Tax | $16.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.9M | -42.5% |
| Accounts Receivable | $80.5M | -3.6% |
| Current Assets | $930.1M | -4.7% |
| Total Assets | $2.39B | -4.2% |
| Current Liabilities | $1.18B | -5.6% |
| Long-term Debt | $1.11B | +3.0% |
| Total Liabilities | $2.31B | -2.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $265.6M | -10.3% |
| Capital Expenditures | $7.8M | +4.4% |
| Investing Cash Flow | -$74.9M | -2.1% |
| Financing Cash Flow | -$247.4M | -77.5% |
| Free Cash Flow | $257.8M | -10.7% |
| +159.2% |
| Net Income | $115.0M | +140.6% |
| EPS (Basic) | $2.41 | +143.0% |
| EPS (Diluted) | $2.37 | +142.3% |
| Stockholders' Equity |
| $85.1M |
| -40.1% |